Position
Chief Strategy Officer
Company
Azora Therapeutics, Inc. (DE)
EncinoBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalDescription
Julie Saiki became Chief Strategy Officer of Adial Pharmaceuticals on October 28, 2026, per the SEC Form 3 filed October 30, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
Quick answer
Adial Pharmaceuticals Names Julie Saiki Chief Strategy Officer (October 31, 2026). Azora Therapeutics, Inc. (DE) is based in Encino, California, United States.
- Who is the new Chief Strategy Officer at Azora Therapeutics, Inc. (DE)?
- Azora Therapeutics, Inc. (DE) named Julie Saiki Chief Strategy Officer, announced October 31, 2026.
- What did Azora Therapeutics, Inc. (DE) announce on October 31, 2026?
- Julie Saiki became Chief Strategy Officer of Adial Pharmaceuticals on October 28, 2026, per the SEC Form 3 filed October 30, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
- Where is Azora Therapeutics, Inc. (DE) based?
- Azora Therapeutics, Inc. (DE) is based in Encino, California, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (November 2, 2026), Retension Pharmaceuticals (October 23, 2026), Os Therapies (October 1, 2026) and Aquestive Therapeutics, Inc. (September 29, 2026) also announced leadership changes within 45 days of Azora Therapeutics, Inc. (DE).
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- AlzeCure Pharma Appoints Johan Sandin as Acting CEO and Pontus Forsell as Deputy CEO (November 1, 2026)
- Crispr Therapeutics names Sivakesava Sakhamuri Chief Technical Officer (November 3, 2026)
Who to call at Azora Therapeutics, Inc. (DE), and when
A new leader at Azora Therapeutics, Inc. (DE) brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Azora Therapeutics, Inc. (DE) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Azora Therapeutics, Inc. (DE), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Azora Therapeutics, Inc. (DE). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Azora Therapeutics, Inc. (DE) changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Azora Therapeutics, Inc. (DE) changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.